Joan Prat Selected Research

N(epsilon)-(malondialdehyde)lysine

6/2005

Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan Prat Research Topics

Disease

2	Hyperglycemia 01/2012 - 05/2002
2	Diabetes Complications 01/2012 - 05/2002
1	Usher Syndromes (Usher Syndrome) 01/2020
1	Obesity 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 05/2014
1	Sclerosis 05/2014
1	Hyperpigmentation 05/2014
1	Atrophy 05/2014
1	Hypercholesterolemia 01/2012
1	Atherosclerosis 01/2012
1	Alzheimer Disease (Alzheimer's Disease) 06/2005

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2020 - 06/2005
2	Retinaldehyde (Retinal)IBA 01/2020 - 05/2014
1	SterolsIBA 01/2020
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 05/2014
1	Superoxides (Superoxide)IBA 01/2012
1	Blood Proteins (Serum Proteins)IBA 01/2012
1	Biological ProductsIBA 06/2005
1	Docosahexaenoic AcidsIBA 06/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2005
1	Receptor for Advanced Glycation End ProductsIBA 06/2005
1	N(6)-(1-carboxyethyl)lysineIBA 06/2005
1	Proteins (Proteins, Gene)FDA Link 06/2005
1	N(epsilon)-(malondialdehyde)lysineIBA 06/2005
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 06/2005
1	Amino Acids FDA Link 06/2005
1	Advanced Glycation End ProductsIBA 05/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2014